chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine (1st booster), it was sore to begin with and kept rubbing it.  She was fine and woke up on 1/19/22 and could not move her arms.  She went to her doctor and told him that she could dress herself.  He watched her try to move her arms, and she could not open her arms to give a hug.  He turned her hands over and the arm was bluish in color from her wrist to her under arms on both arms.  He looked at them and ordered lab work.  She then went back and as she was still having problems with her arms.  She then had an US, then ordered an EMG, x-rays, and another US.  The US was checked by the orthopedist that showed that she had a tear in her left shoulder, but had something in her right arm.  She is going back on 5/4/22 to get her results.  She was put on Gabapentin for her symptoms, and tizanidine 4 mg which she did not like the feeling and did not take any more and did not help her.  Then she was given Melatonin for her nerves.   She could not lift her arms, and had to help her get redressed.  She said the pain was a 10.    She has not been able to sleep at night as she cannot lie on her arms, and has tears from the pain.  She was fine until she got the vaccine with no arm pain.  She has an apt with neurologist on 5/12/22, and pulmonologist on 7/25/22, had one earlier but she was not able to get dressed to make the appointment.    She was also given steroid injections in her shoulders, the one in the right arm worked but the left one did not and therapy was ordered, but she is not able to go yet due to the pain.  She has the swelling as in the picture of COVID arm, but also has swelling in her middle two fingers where she cannot hold anything and it also affects her wrist.  She cannot lean onto her elbow as the pain shoots up into her muscle, and she can feel pain in her right arm when she lends on her left arm.   Her left arm, the entire arm gets feverish and she just wants the pain to go away and find out what is wrong.  She is limited in what she can do due to the pain.  Her right arm is finally moving some as she can brush her hair, but not with the left arm, and cannot put her hair in a pony tail which is usually how she wears her hair.  Her right arm also pops.
Tuesday- Headache, temp from 97 to 98.1. Took Tylenol. Headache didn't go away.  Wednesday- temp ranged from 100.0 to 101.0 Thursday- no temperature
Swelling, soreness, low-grade fever, MD stated it is infected (cellulitis), rash on torso.
A solicited report had been received from health professional via Post-Licensure Surveillance of FLUMIST QUADRIVALENT from regulatory authority concerning a 21 year old male patient. Concomitant medications included yellow fever vaccine and hepatitis B vaccine. No information regarding relevant history and concurrent disease of the patient was provided. The patient had been receiving FLUMIST QUADRIVALENT (intranasal) unknown frequency, started on an unknown date for an unknown indication. The patient presented symptoms that met Brighton level 2 criteria, anaphylaxis. Action taken with FLUMIST QUADRIVALENT was unknown. The patient recovered from the event of anaphylaxis on an unspecified date. The company physician upgraded reported non-serious event of anaphylaxis to serious with serious criteria of important medical event. Based on the information in this report, and awaiting the assessment of the reporter, the company physician considered the event of anaphylaxis to be related to the vaccine FLUMIST QUADRIVALENT.
rt shoulder & arm swollen & bruised swelling extended to shoulder blade & very tender to touch;ice applied to area;14AUG98 spoke to mom;area less swollen but still very tender to touch;
9APR98 mom c/o redness & swelling bilat thighs, immun 7APR98;rt thigh small amount erythema & swelling approx 15x20cm;lt thigh mod amount erythema, swelling w/induration 30x40cm;T97.9;mom states APAP given;MD called for eval
Initial report was received from a consumer, who was also the patient, on 13 December 2012. A 51-year-old female patient had received an injection of INFLUENZA VACCINE (manufacturer, lot number, route and site not reported) on 10 October 2012 and on 23 November 2012 experienced the flu which lasted until 27 November 2012. She experienced chills, fever and cough. Outcome was recovered. Documents held by sender: None.
This spontaneous report was received from a physician refers to a female patient of unknown age who on an unknown date, in 2012, was vaccinated intramuscularly with the first dose of GARDASIL (dose and lot number not reported) and in July 2012, was vaccinated with the second dose of GARDASIL (dose and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The physician reported that two weeks after first vaccination, in 2012, the patient had an unspecified allergic reaction. The patient went to the emergency room and was given BENADRYL as a treatment for the experience. In approximately July 2012, after second vaccination, the patient displayed the same unspecified allergic reaction. At the time of the report, the patient's outcome was unknown. The relatedness for the patient had an unspecified allergic reaction after first dose of GARDASIL and the patient displayed the same unspecific allergic reaction after second dose of GARDASIL was unknown for GARDASIL. Additional information has been requested.
Day 0- Fever over 103 , chills, body aches, headache cough. Fever >100, cough, chills, body aches, light headed, dizzy, headache (12/17-12/19).
Patient hospitalized for COVID-19 on 7/23/21. Laboratory confirmed COVID-19 symptoms and diagnostic evaluation consistent with COVID-19 infection. Patient is currently hospitalized on supplemental oxygen receiving recommended treatments for COVID-19 Infection. Outcome to be determined.
Pt received Pneumovax vaccine on 9/10/99 and had onset of fever, headache and diarrhea on 9/13/99. He was admitted to the hospital on 9/15/99 with dx of pneumonia. He was treated withlevofloxacin. On 9/22/99, temperature was 104.
Patient received Pfizer vaccine on 3/5/21. On 3/13/21 patient had fever, headache, diarrhea and tested positive for COVID 19 on 3/15/21 in our office.
Cryptogenic - Acute Ischemic Stroke 15 days after booster.  Have had every scan/test under the sun, and docs can't find anything wrong with me.   Brain, heart, and full body MRI's, blood work, stress tests.....
"Achy" am after vaccinations. Given Motrin by parent at 4:30 pm and 11:00 pm on 8-18-08. Also complained of feeling "nervous, restless" at 10:30 pm on 8-18-08. Did not fall asleep until 2:30 am. Slept through night until 9:00 am on 8-19-08. On 8-19-08, feels o.k. - no restlessness. Plans to inform physician.
pt c/o dizziness 15-20 after vaccine.  B/P 154/104  HR63 O2 sat 100%.  states no history of hypertension.  C/o having a busy day at work. B/P recheck 3 mins later 154/85.  Vaccine given at 454pm.  Pt not feeling better at 6:40pm.  Sent pt to ER.  Still with dizziness.  Able to walk but unable to drive per pt.  Gave juice and cookies to pt starting at 5:15pm.  did not improve her status
Before receiving the HPV immunization, this RN had administered the flu shot and meningococcal vaccine in her LA.  Client then received HPV IM in RA and tolerated it well, client did say it was the most painful shot she received of the  three, but tolerated all shots well. After stating the shot was painful, the client was rubbing her arm. After about 30 seconds, the client's face and lips got very pale and then she slumped forward and to the right, into her brother's lap, and then proceeded to slide down to the floor with this RN protecting and guiding client's upper body and head safely to the ground.  Client did not respond to name at that time. Once client was laying on ground, client started responding to her name being called by mother and RN within 15 seconds. Client oriented x3 upon responding, but feeling nauseated, color returning to face at this time. Client assisted to sitting position, with head between her legs. Client given water and orange juice and encouraged to move slowly after sitting for 10 minutes. Mother states client did not eat breakfast before appointment. Client felt better after sitting for the 10 minutes and was able to walk out of clinic.
Swelling and redness on inside of right arm, beginning about midway down upper inside arm and continuing below the elbow to about halfway down lower arm.
2 days after getting his Hepatitis A, Varicella, and MMR, the patient developed hives on his right thigh, where the Varivax was given.  Over the next day, the hives became widespread and severe, his right ear doubled in size, he had a decreased appetite, and a chicken-pox like rash developed, although there was no other systemic involvement.  Because of the degree of reaction and the patient's pruritis, we had to start oral steroids, 3 days after live vaccines were given.   I know the varicella like rash is normal, but the hives are not.  The patient was on Amoxicillin at the time of the vaccines being given, but the hives specifically started around the injection site on the right thigh.  Now I'm having trouble getting answers as to whether this MMR and Varicella can count as dose 1, since he's been put on oral steroids (2 mg/kg/day) for 3 days for the reaction.
No additional AE; Caller explained a patient was administered MMR II after the expiration date.; This spontaneous report was received from pharmacist and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 11-MAY-2022, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) albumin status recombinant Human albumin (rHA) lot #T000892, expiration date: 08-JAN-2022 (expired product administered) (dose, route of administration and injection site were not provided) for prophylaxis.Caller confirmed the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) has not had any temperature excursions. No additional AE was reported (No adverse event).
Itchiness; Red Spot; Swelling; Sore Arm; Bump; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Bump), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Sore Arm), VACCINATION SITE ERYTHEMA (Red Spot) and VACCINATION SITE SWELLING (Swelling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concomitant products included RETINOL, ARGININE HYDROCHLORIDE, IBUPROFEN (ALPAIN [ARGININE HYDROCHLORIDE;IBUPROFEN]), LEVOMEPROMAZINE MALEATE (METHOPRAZINE), DANAZOL and MAGNESIUM for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Bump) and VACCINATION SITE PAIN (Sore Arm). On 15-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Spot) and VACCINATION SITE SWELLING (Swelling). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INDURATION (Bump), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (Sore Arm), VACCINATION SITE ERYTHEMA (Red Spot) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up information was received. Patient reported she does not want to share email. It contains no new information.
After first injection a visible swelling of my lymph node in my right neck. I did some online research wwhich lead me to conclude that this side effect was possible in people that had Covid prior to the vaccination. (I tested positive in July of 2020). I also concluded it would go away.  I went to my 2nd injection appointment as scheduled and on site I inquired about my (still) swollen lymph node and the nurse assured me it would go away. After my second injection my lymph nodes under both arms became VERY visibly swollen and my neck swelling increased. I spoke with a friend who had a similar issue and he said his went away after 11 days after his second shot. I waited 11 days then went to Urgent Care. The tests performed are listed as well as I can (I lost my test result paper)
Initial case was received from a health care professional on 04 October 2013. A 74 years old female patient had no medical history reported, received a dose FLUZONE HD vaccine intramuscularly in left deltoid 03 October 2013 (batch number U4760AA). Patient had not reported concomitant medication. It was reported that on 04 October 2013 patient experience left arm was purple like the size of a quarter. No corrective treatment was reported. At the time of report the outcome of event was not recovered.
Exceptional amount of pain at injection site with weakness and tingling radiating down arm to middle finger.
constant extreme exhaustion, pain in extremities, dizziness, headache, diarrhea,
17 year old; received first dose Moderna in error so was given second dose Moderna as per CDC guidance.  No AE.
ADMINISTRATION ERROR : Pt. states that after receiving the 1st dose of Phizer 10/01/2021, was notified of  EXPIRATION DATE : 09/26/2021 for Phizer Dosage given 10/01/2021. Experiencing heavy headiness' and fatigue.
Extreme constant pain at injection site and top half of arm.  From elbow to shoulder, arm feels extremely hot; this has led to an elevated body temperature for me.  The injection site is raised and red and is barely 1 fingers width from the top of my shoulder.  Cannot sleep, as the pain is excruciating to the touch.  Shoulder hurts constantly.
first dose on 22Mar2021, tested positive for SARS-Cov-2 on 31Mar2021/tested positive for CoVid March 31st; This is a spontaneous report from a contactable other hcp. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 22Mar2021 (Lot number: unknown) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported.  On 31Mar2021, the patient experienced first dose on 22mar2021, tested positive for sars-cov-2 on 31mar2021/tested positive for COVID march 31st. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive on 31Mar2021. The patient was scheduled for second dose for on 12Apr2021 (day if reporting) and was looking for recommendation. The patient also asked about the interval for second dose, how it is given and whether the patient should have 2nd dose of vaccine or not. The outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
"No PMH, Allergies, or medications on file. 9mins post vaccination pt c/o flushing/sweating, dizziness/lightheadedness, clammy skin.  Pt was notably pale. Vitals: @10:39 BP 95/57, HR 55, RR 18, O2Sat 96% -- > @10:45 107/60, 54, 18, 100% (0 symptoms reported) -- > @10:54 107/57, 56, 99% Pt given water, juice and crackers.  Pt reportes relief of adverse symptoms and states he is feeling better. Pt reports prior anxiety w/ needle sticks.  Pt did not eat before vaccination and was feeling anxious before vaccination. @10:54 pt denies any symptoms.  Educated pt on prevention of vasovagal symptoms in the future @10:57 Pt ambulates independently, gait steady.  Pt stable and released from the vaccination site.  Pt left accompanied by friend."
Pt recvd vax 11NOV94 & sids death 12NOV93;
cold; fever; nausea; chills; low energy; dry heaves; itching; skin lesions; This case was reported by a consumer via call center representative and described the occurrence of cold sweat in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced cold sweat, fever, nausea, chills, energy decreased, dry heaves, pruritus and skin lesion. On an unknown date, the outcome of the cold sweat, fever, nausea, chills, energy decreased, dry heaves, pruritus and skin lesion were unknown.   It was unknown if the reporter considered the cold sweat, fever, nausea, chills, energy decreased, dry heaves, pruritus and skin lesion to be related to Shingrix.  Additional details were provided as follows: The case was reported by the reporter for her sister in law. The age at vaccination was not reported. The patient received Shingrix and had symptoms that included cold Sweats, chills, fever, nausea, low energy, lesion, itching and dry heaves and skin lesion. This case linked with US2020147972, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020147972:same reporter
Patient fainted approximately 5 minutes post IM injection. Patient was diaphoretic. Patient unable to keep eyes open for brief period and reported feeling like he was going to faint for a second time. This writer contacted EMS services. When EMS arrived patient reported feeling better. EMS evaluated patient. Patient declined transport to hospital. Patient stayed in-store for another 20 minutes. This writer advised patient not to leave without telling this writer. Patient left facility at approximately 10:50am.
Narrative:  COVID infection following COVID vaccine series 05/20 Janssen, dose #1 09/23 human metapneumovirus: detect 10/13 CXR impression: No acute findings in the chest 10/18 COVID swab, result: detected 10/18 pt cc: cough, diarrhea, fatigue, fever, rhinorrhea myalgias, sore throat, sinus and chest congestion exposure: unknown 10/18 BNP: 16.8 10/18 SARS-COV-2 Variant Sequencing result: pending 10/18 LACTIC ACID: 0.88 10/18 CXR impression: Streaky peribronchial opacities emanating from both hila may reflect ongoing bronchitis. No pneumonia, pleural effusion or solid mass. 1027 pt admit cc: dyspnea, dry cough, and malaise dx: covid infection, pneumonia LOS: 4 days 10/27 TROPONIN I: <0.016 10/27 BNP: 44.0 10/27 FIBRINOGEN: 602 10/27 DDIMER: 0.49 10/27 FERRITIN: 433.8 10/27 LACTIC ACID: 1.59 10/27 PROCALCITONIN: <0.05 10/27 CXR impression: impression: Bilateral lung opacities would be consistent with COVID pneumonia in the reported clinical setting. 10/28 FIBRINOGEN: 555 10/28 DDIMER: 0.43 10/28 ESR: 55 10/29 FIBRINOGEN: 503 10/29 DDIMER: 0.42 10/29 ESR: 47 10/30 FIBRINOGEN: 414 10/30 DDIMER: 0.37 10/30 ESR: 38
Pt received FLUBLOK QUADRIVALENT and PNEUMOVAX 23 in the right deltoid on 10/1/18 at 14:37. Pt describes severe shoulder pain and limited range of motion about 2 hours later. Pt self-reported significant shoulder pain and severely limited range of motion to PCP on 10/5/18. Orthopedist was consulted and dx of shoulder injury related to vaccine administration (SIRVA) was discussed; pt was referred to orthopedic specialist on that same day for evaluation. Pt seen by PA in orthopedist's office. Per notes from 10/5/18 ortho visit, pt's pain and limited ROM persisted over the 4 days with some improvement, but still reported intermittent pain at 10/10, despite naproxen twice daily, which provided no relief. Physical findings from ortho exam: bandaids from vaccine administration were in place 3 fingers below the right acromion of the lateral arm; non-tender to palpation. passive range of motion caused pain over 160 degrees of forward flexion, 90 degrees of abduction. Pain was present with Hawkins and Neer impingement; Positive drop arm. Deltoid strength 2/5 in neutral; triceps strength 1/5; biceps strength intact. Assessment from PA and attending physician was that patient may have developed SIRVA. Pt was referred to PT and given a Medrol Dose Pak.
flu symptoms; headache was similar to a migraine; having some vasovagal symptoms that show his "veins are popping" on the sides of his head; very low grade fever but his body was still emitting heat with a temperature of 99F; pretty severe headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (flu symptoms), MIGRAINE (headache was similar to a migraine), PRESYNCOPE (having some vasovagal symptoms that show his "veins are popping" on the sides of his head), PYREXIA (very low grade fever but his body was still emitting heat with a temperature of 99F) and HEADACHE (pretty severe headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced INFLUENZA (flu symptoms), MIGRAINE (headache was similar to a migraine), PRESYNCOPE (having some vasovagal symptoms that show his "veins are popping" on the sides of his head), PYREXIA (very low grade fever but his body was still emitting heat with a temperature of 99F), HEADACHE (pretty severe headache), CHILLS (chills) and PYREXIA (fever). At the time of the report, INFLUENZA (flu symptoms), MIGRAINE (headache was similar to a migraine), PRESYNCOPE (having some vasovagal symptoms that show his "veins are popping" on the sides of his head), PYREXIA (very low grade fever but his body was still emitting heat with a temperature of 99F), HEADACHE (pretty severe headache), CHILLS (chills) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 99f (High) body temperature little bit high.         Concomitant medication was not provided. Treatment medication include Tylenol and ibuprofen.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
I received 2nd dose of Pfizer vaccine on 25th Apr-2021. On 26th Apr, I felt some dizziness, body aches and sleepiness all the day. In the late night of 26th Apr while I was sleeping, suddenly I felt serious gastric problems. It also felt like heartburn. I walked around 2 hours in my apartment in the late night. I had plenty of water also. I had to take some Coke to burp up the gas.  After ~2 to 3 hours, I relaxed. Maybe this is not a serious adverse event, but as a responsible person, I had to share my experience.
Patient said she had soreness at injection site which started about 6 hours after administration. On pain scale 1-10 the highest score she rated the pain was a 3. She also experienced a low grade fever which started about 18 - 20 hours after administration and lasted about 8 - 10 hours.
Employee states that she woke up Monday morning, stretched and had a "horrific" pain in arm where the vaccine shot was given.  Pain persists in the arm for 5 days.  Has taken Tylenol/motrin for pain without relief.  Pain improved over the weekend and did not seek medical treatment.
Late in the evening on February 10, I had a cough, nasal congestion, it felt like I had the flu. I used an at home COVID-19 test that came back positive. On Saturday I went to a local Immediate Care and had them retest and Rapid PCR COVID-19 test also came back positive.   I was prescribed molnupiravir that I started taking immediately, along with benzonatate for the cough. I was feeling better within nine days and much better today.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/16/2021 2nd dose01/07/2021 Diagnosed covid positive:08/30/21 Symptom onset:08/26/21 Exposure:Travel Symptoms:fever, cough, headache
Pt arm deltoid swelled and had whelps, eyes itching, complained throat hurt to swallow, face slightly swelled administered Benadryl 25 mg IM and Depo medal  40 mg IM.
Skin eruption on right side of forehead. Acyclovir and mupirocin ointment.